FDA-Inspected Site

Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

23 FDA inspections are on record for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company in Manati, United States.

483· Form 483 issued

Manati, United States · Last updated July 9, 2026

Overview

  • 23 FDA inspections are on record.
  • 10 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-02-13.

At a glance

Inspections

23

Form 483s

10

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
12 Jan 2026 – 13 Feb 2026Human Drugs483On file
29 May 2024 – 6 Jun 2024Human Drugs483On file
11 May 2021 – 12 Jul 2021Human Drugs483View 483 →
4 Nov 2019 – 19 Nov 2019Human Drugs483View 483 →
15 Jan 2019 – 6 Feb 2019Human Drugs483On file
15 Aug 2017 – 11 Sep 2017Human Drugs483On file
10 May 2016 – 18 May 2016Human DrugsClean
9 Nov 2015 – 17 Nov 2015Medical Devices & Rad HealthClean
5 May 2014 – 16 May 2014Human DrugsClean
22 Jun 2012Not recordedClean
19 Jan 2012Not recordedClean
28 Mar 2011Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

12 Jul 2021
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Libia M Lugo, Adaliz Santaliz-Cruz, Jose F Velez

12 Jul 2021
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Libia M Lugo, Adaliz Santaliz-Cruz, Jose F Velez

12 Jul 2021
21 CFR 211.165(d)

Acceptance criteria for sampling & testing

Cited by Libia M Lugo, Adaliz Santaliz-Cruz, Jose F Velez

12 Jul 2021
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Libia M Lugo, Adaliz Santaliz-Cruz, Jose F Velez

12 Jul 2021
21 CFR 211.56(a)

Sanitation--buildings not clean, free of infestation

Cited by Libia M Lugo, Adaliz Santaliz-Cruz, Jose F Velez

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations5x
21 CFR 211.100(b)Cited across public-safe Form 483 observations3x
21 CFR 211.22(d)Cited across public-safe Form 483 observations3x
21 CFR 211.56(a)Cited across public-safe Form 483 observations3x
21 CFR 211.100(a)Cited across public-safe Form 483 observations2x
21 CFR 211.110(a)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations2x
21 CFR 211.22(c)Cited across public-safe Form 483 observations2x
21 CFR 211.25(a)Cited across public-safe Form 483 observations2x
21 CFR 211.110(d)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(f)Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 10 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat